Non-coding RNA Activated by DNA Damage: Review of Its Roles in the Carcinogenesis

Overview

Journal Front Cell Dev Biol

Specialty Cell Biology

Date 2021 Sep 6

PMID 34485302

Citations 10

Authors

Soudeh Ghafouri-Fard

Tahereh Azimi

Bashdar Mahmud Hussen

Atefe Abak

Mohammad Taheri

Nader Akbari Dilmaghani

Affiliations

Soon will be listed here.

Abstract

Long intergenic non-coding RNA 00657 (LINC00657) or "non-coding RNA activated by DNA damage" (NORAD) is an extremely conserved and copious long non-coding RNA (lncRNA). This transcript has pivotal role in the preservation of genome integrity. Several researches have appraised the role of NORAD in the evolution of human cancers with most of them indicating an oncogenic role for this lncRNA. Several miRNAs such as miR-199a-3p, miR-608, miR-155-5p, miR-590-3p, miR-495-3p, miR-608, miR-202-5p, miR-125a-3p, miR-144-3p, miR-202-5p, and miR-30a-5p have been recognized as targets of NORAD in different cancer cell lines. In addition, NORAD has interactions with cancer-related pathways, particularly STAT, TGF-β, Akt/mTOR, and PI3K/AKT pathway. Over-expression of NORAD has been related with poor clinical outcome of patients with diverse types of neoplasms. Collectively, NORAD is a prospective marker and target for combating cancer.

Citing Articles

Role of Hypoxia-Associated Long Noncoding RNAs in Cancer Chemo-Therapy Resistance.

Elahi M, Tariq A, Malik A, Zhra M Int J Mol Sci. 2025; 26(3).

PMID: 39940704 PMC: 11817469. DOI: 10.3390/ijms26030936.

Oncogenic role of and its ceRNA network in hepatocellular carcinoma based on a comprehensive analysis.

Hu W, Hu X, Zhu Y, Li M, Meng H, Zhao H Transl Cancer Res. 2024; 13(10):5190-5201.

PMID: 39525023 PMC: 11543042. DOI: 10.21037/tcr-24-833.

-Regulated Signaling Pathways in Breast Cancer Progression.

Capela A, Tavares-Marcos C, Estima-Arede H, Nobrega-Pereira S, de Jesus B Cancers (Basel). 2024; 16(3).

PMID: 38339387 PMC: 10854850. DOI: 10.3390/cancers16030636.

"Salivary LINC00657 and miRNA-106a as diagnostic biomarkers for oral squamous cell carcinoma, an observational diagnostic study".

Abdel Fattah Tarrad N, Hassan S, Shaker O, Abdelkawy M BMC Oral Health. 2023; 23(1):994.

PMID: 38087258 PMC: 10714514. DOI: 10.1186/s12903-023-03726-0.

Expression of correlates with breast cancer aggressiveness and protects breast cancer cells from chemotherapy.

Alves-Vale C, Capela A, Tavares-Marcos C, Domingues-Silva B, Pereira B, Santos F Mol Ther Nucleic Acids. 2023; 33:910-924.

PMID: 37680988 PMC: 10480464. DOI: 10.1016/j.omtn.2023.08.019.

References

Tao W, Li Y, Zhu M, Li C, Li P . LncRNA NORAD Promotes Proliferation And Inhibits Apoptosis Of Gastric Cancer By Regulating miR-214/Akt/mTOR Axis. Onco Targets Ther. 2019; 12:8841-8851. PMC: 6826994. DOI: 10.2147/OTT.S216862. View

Yu S, Peng H, Zhu Q, Wu Y, Wu F, Han C . Silencing the long noncoding RNA NORAD inhibits gastric cancer cell proliferation and invasion by the RhoA/ROCK1 pathway. Eur Rev Med Pharmacol Sci. 2019; 23(9):3760-3770. DOI: 10.26355/eurrev_201905_17802. View

Lee S, Kopp F, Chang T, Sataluri A, Chen B, Sivakumar S . Noncoding RNA NORAD Regulates Genomic Stability by Sequestering PUMILIO Proteins. Cell. 2016; 164(1-2):69-80. PMC: 4715682. DOI: 10.1016/j.cell.2015.12.017. View

Zhao L, Liu C, Yan S, Hu G, Xiang K, Xiang H . LINC00657 promotes colorectal cancer stem-like cell invasion by functioning as a miR-203a sponge. Biochem Biophys Res Commun. 2020; 529(2):500-506. DOI: 10.1016/j.bbrc.2020.04.049. View

Zhang J, Li X, Hu P, Ding Y . lncRNA NORAD Contributes to Colorectal Cancer Progression by Inhibition of miR-202-5p. Oncol Res. 2018; 26(9):1411-1418. PMC: 7844737. DOI: 10.3727/096504018X15190844870055. View

Zhang Y, Li Y . Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway. Cancer Cell Int. 2020; 20(1):571. PMC: 7694907. DOI: 10.1186/s12935-020-01665-2. View

Chen Y, Cao K, Li J, Wang A, Sun L, Tang J . Overexpression of long non-coding RNA NORAD promotes invasion and migration in malignant melanoma via regulating the MIR-205-EGLN2 pathway. Cancer Med. 2019; 8(4):1744-1754. PMC: 6488211. DOI: 10.1002/cam4.2046. View

Yang X, Cai J, Peng R, Wei C, Lu J, Gao C . The long noncoding RNA NORAD enhances the TGF-β pathway to promote hepatocellular carcinoma progression by targeting miR-202-5p. J Cell Physiol. 2018; 234(7):12051-12060. PMC: 6590789. DOI: 10.1002/jcp.27869. View

Munschauer M, Nguyen C, Sirokman K, Hartigan C, Hogstrom L, Engreitz J . The NORAD lncRNA assembles a topoisomerase complex critical for genome stability. Nature. 2018; 561(7721):132-136. DOI: 10.1038/s41586-018-0453-z. View

10.

Miao Z, Guo X, Tian L . The long noncoding RNA NORAD promotes the growth of gastric cancer cells by sponging miR-608. Gene. 2018; 687:116-124. DOI: 10.1016/j.gene.2018.11.052. View

11.

Utnes P, Lokke C, Flaegstad T, Einvik C . Clinically Relevant Biomarker Discovery in High-Risk Recurrent Neuroblastoma. Cancer Inform. 2019; 18:1176935119832910. PMC: 6413431. DOI: 10.1177/1176935119832910. View

12.

Chen Z, Che Q, Xie C . NORAD regulates epithelial‑mesenchymal transition of non‑small cell lung cancer cells via miR‑422a. Mol Med Rep. 2020; 23(2). PMC: 7723171. DOI: 10.3892/mmr.2020.11750. View

13.

Li H, Wang X, Wen C, Huo Z, Wang W, Zhan Q . Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Mol Cancer. 2017; 16(1):169. PMC: 5679488. DOI: 10.1186/s12943-017-0738-0. View

14.

Yu Y, Chen F, Jin Y, Yang Y, Wang S, Zhang J . Downregulated NORAD in neuroblastoma promotes cell proliferation via chromosomal instability and predicts poor prognosis. Acta Biochim Pol. 2020; 67(4):595-603. DOI: 10.18388/abp.2020_5454. View

15.

Zhao W, Wang L, Xu F . LncRNA NORAD stimulates proliferation and migration of renal cancer via activating the miR-144-3p/MYCN axis. Eur Rev Med Pharmacol Sci. 2020; 24(20):10426-10432. DOI: 10.26355/eurrev_202010_23394. View

16.

Huang Q, Xing S, Peng A, Yu Z . NORAD accelerates chemo-resistance of non-small-cell lung cancer via targeting at miR-129-1-3p/SOX4 axis. Biosci Rep. 2020; 40(1). PMC: 6981097. DOI: 10.1042/BSR20193489. View

17.

Sun D, Guan C, Wang W, Hu Z, Zhao Y, Jiang X . LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis. Microvasc Res. 2020; 134:104120. DOI: 10.1016/j.mvr.2020.104120. View

18.

Hu C, Chen J, Qin X, You P, Ma J, Zhang J . Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer. J Exp Clin Cancer Res. 2021; 40(1):98. PMC: 7962263. DOI: 10.1186/s13046-021-01891-0. View

19.

Lei Y, Wang Y, Wang X, Bai J . LINC00657 promotes the development of colon cancer by activating PI3K/AKT pathway. Eur Rev Med Pharmacol Sci. 2018; 22(19):6315-6323. DOI: 10.26355/eurrev_201810_16042. View

20.

Gao W, Weng T, Wang L, Shi B, Meng W, Wang X . Long non‑coding RNA NORAD promotes cell proliferation and glycolysis in non‑small cell lung cancer by acting as a sponge for miR‑136‑5p. Mol Med Rep. 2019; 19(6):5397-5405. PMC: 6522956. DOI: 10.3892/mmr.2019.10210. View